Advertisement

Topics

RedHill Biopharma Reports 2017 Third Quarter Financial Results

08:49 EST 13 Nov 2017 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
RedHill maintains a debt-free balance sheet with $39.6 million in cash1 at the end of the third quarter of 2017 In addition, an underwritten public offering of the Company's American Depositary Shares (ADSs) is scheduled to be closed today, N...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "RedHill Biopharma Reports 2017 Third Quarter Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.